title: Response Entropy is not more sensitive than State Entropy in distinguishing the use of esmolol instead of remifentanil in patients undergoing gynaecological laparoscopy.
abstract: BACKGROUND
  Monitoring of analgesia remains a challenge during general anaesthesia. Activation of Response Entropy (RE) to painful stimuli has been suggested to be a sign of inadequate analgesia. We evaluated the ability of RE to be more sensitive than State Entropy (SE) in measuring nociception in patients undergoing gynaecological laparoscopy. Our hypothesis was that while keeping SE at a predetermined level, RE would be higher in patients receiving a beta-blocking agent (esmolol) instead of an opioid (remifentanil) during a propofol/nitrous oxide anaesthesia.
  
  
  METHODS
  Fifty-one women aged between 22-53 years were randomly assigned to receive esmolol (n=25) or remifentanil (n=26). SE was kept at 50+/-5. RE and SE were recorded at an interval of 30 s to 2 min and the areas under the RE and SE value-time curves (AUCRE and AUCSE) were calculated during the time of intubation and start of surgery as well as during the entire anaesthesia. The difference between RE and SE recordings in both groups was determined by subtracting the AUCSE from the corresponding AUCRE. Movements of the patients were recorded.
  
  
  RESULTS
  No significant differences were detected in any of the several AUC values between the groups. The difference between RE and SE recordings was similar in both groups. Every patient in the esmolol group moved some time during the procedure interfering with surgery while no one in the remifentanil group moved.
  
  
  CONCLUSIONS
  In patients undergoing gynaecological laparoscopic day-case surgery, RE seems not to be more sensitive than SE in guiding the use of opioids during general anaesthesia.
authors.affiliation: Department of Anaesthesia and Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland.
authors.forename: M
authors.initials: M
authors.lastname: Valjus
authors.forename: J
authors.initials: J
authors.lastname: Ahonen
authors.forename: R
authors.initials: R
authors.lastname: Jokela
authors.forename: K
authors.initials: K
authors.lastname: Korttila
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000328:Adult; D000556:Ambulatory Surgical Procedures; D000768:Anesthesia, General; D018686:Anesthetics, Intravenous / Q000008:administration & dosage*; D019540:Area Under Curve; D004569:Electroencephalography; D004576:Electromyography; D004715:Endometriosis / Q000601:surgery; D005260:Female; D013509:Gynecologic Surgical Procedures; D006801:Humans; D010535:Laparoscopy; D008875:Middle Aged; D016343:Monitoring, Intraoperative; D010048:Ovarian Cysts / Q000601:surgery; D010147:Pain Measurement; D010880:Piperidines / Q000008:administration & dosage*; D011412:Propanolamines / Q000008:administration & dosage*; D015742:Propofol; D000077208:Remifentanil
chemical_list: D000319:Adrenergic beta-Antagonists; D018686:Anesthetics, Intravenous; D010880:Piperidines; D011412:Propanolamines; C036604:esmolol; D000077208:Remifentanil; D015742:Propofol